Literature DB >> 10376917

The valve of Vieussens: an important cause of difficulty in advancing catheters into the cardiac veins.

S J Corcoran1, C Lawrence, M A McGuire.   

Abstract

INTRODUCTION: The coronary sinus and cardiac veins are useful conduits for the passage of electrode catheters for mapping the origin of cardiac arrhythmias. However, sometimes it is difficult to advance catheters an adequate distance into the cardiac veins. The aim of this study was to determine the reasons for this. METHODS AND
RESULTS: In 50 cadaveric hearts, a deflectable 7-French electrode catheter was passed from the right atrium into the coronary sinus and advanced to the anterior interventricular portion of the great cardiac vein (GCV). Causes of obstruction were determined. The catheter was obstructed by the valve of Vieussens in 23 of 50 hearts (46%). Once the valve was negotiated, obstruction was caused by an acute bend in the GCV in 28 of 50 hearts (56%). Clinical studies were undertaken in 10 patients in whom electrode catheters could not be advanced as far as required. Using contrast venography, the most frequent cause of obstruction was determined to be the valve of Vieussens in 8 of 10 cases (80%). An acute bend in the GCV caused obstruction in 2 cases (20%).
CONCLUSIONS: The valve of Vieussens is a frequent cause of obstruction to passage of a catheter in postmortem and in vivo studies. An acute bend in the vein, with or without lodgment in a tributary, is the other common cause. In adults, venous luminal diameter is not a cause of obstruction to the passage of a 7-French catheter in the coronary sinus or proximal GCV.

Entities:  

Mesh:

Year:  1999        PMID: 10376917     DOI: 10.1111/j.1540-8167.1999.tb00260.x

Source DB:  PubMed          Journal:  J Cardiovasc Electrophysiol        ISSN: 1045-3873


  13 in total

1.  The anatomic barriers in the coronary sinus: implications for clinical procedures.

Authors:  Mustafa Karaca; Okan Bilge; Mustafa Hakan Dinckal; Hulya Ucerler
Journal:  J Interv Card Electrophysiol       Date:  2005-11       Impact factor: 1.900

2.  Venous valves: unseen obstructions to coronary access.

Authors:  Sara E Anderson; Alexander J Hill; Paul A Iaizzo
Journal:  J Interv Card Electrophysiol       Date:  2007-09       Impact factor: 1.900

3.  Venous valves within left ventricular coronary veins.

Authors:  Sara E Anderson; Jason L Quill; Paul A Iaizzo
Journal:  J Interv Card Electrophysiol       Date:  2008-08-09       Impact factor: 1.900

4.  Valve of Vieussens: an obstacle for left ventricular lead placement.

Authors:  Bernhard Strohmer
Journal:  Can J Cardiol       Date:  2008-09       Impact factor: 5.223

Review 5.  Human coronary venous anatomy: implications for interventions.

Authors:  Julianne H Spencer; Sara E Anderson; Paul A Iaizzo
Journal:  J Cardiovasc Transl Res       Date:  2013-01-11       Impact factor: 4.132

6.  Anatomical Consideration and Potential Complications of Coronary Sinus Catheterisation.

Authors:  Lalit Mehra; Shashi Raheja; Sneh Agarwal; Yashoda Rani; Kulwinder Kaur; Anita Tuli
Journal:  J Clin Diagn Res       Date:  2016-02-01

7.  Electrophysiological characteristics of the Marshall bundle in humans.

Authors:  Seongwook Han; Boyoung Joung; Mauricio Scanavacca; Eduardo Sosa; Peng-Sheng Chen; Chun Hwang
Journal:  Heart Rhythm       Date:  2010-02-24       Impact factor: 6.343

8.  Conduction patterns in the cardiac veins: electrophysiologic characteristics of the connections between left atrial and coronary sinus musculature.

Authors:  Demosthenes G Katritsis; Eleftherios Giazitzoglou; Socrates Korovesis; Evangelia Karvouni; Constantine E Anagnostopoulos; A John Camm
Journal:  J Interv Card Electrophysiol       Date:  2004-02       Impact factor: 1.900

9.  Arrhythmogenicity of the coronary sinus.

Authors:  Demosthenes G Katritsis
Journal:  Indian Pacing Electrophysiol J       Date:  2004-10-01

10.  Incidental visualization of the septal vein of the left atrium.

Authors:  Jun Kim; Jeong-Su Kim
Journal:  Korean Circ J       Date:  2013-05-31       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.